Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Molnlycke Health Care AB, commonly known as Molnlycke, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in Sweden (SE). Founded in 1849, the company has established a strong presence in various operational regions, including Europe, North America, and Asia.
Specialising in advanced wound care and surgical solutions, Molnlycke is renowned for its innovative products, such as the Mepilex® range of dressings and the BARRIER® surgical solutions. These offerings are distinguished by their commitment to enhancing patient outcomes and optimising clinical efficiency.
With a rich history marked by significant milestones, Molnlycke has solidified its market position as a trusted partner in healthcare, consistently recognised for its quality and innovation in the pharmaceutical sector.
100
DitchCarbon score
+58 vs industry average
Molnlycke’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Molnlycke?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Molnlycke's reported carbon emissions
Mölnlycke, a Pharmaceutical Preparation Manufacturing company headquartered in Sweden, reported total emissions of approximately 533 million kg CO2e in 2025. This includes Scope 1 emissions of 47.9 million kg CO2e, Scope 2 emissions of 1.9 million kg CO2e (market-based), and Scope 3 emissions of 483.3 million kg CO2e.
Looking back, Mölnlycke's total emissions in 2024 were approximately 548.8 million kg CO2e. In 2023, total emissions were around 518 million kg CO2e, and in 2022, they were about 581.5 million kg CO2e. The company reported total emissions of approximately 648.9 million kg CO2e in 2021.
Mölnlycke has committed to significant climate actions, with Science Based Targets initiative (SBTi) validated targets. The company aims to achieve net-zero greenhouse gas emissions across its value chain by 2050.
Near-term targets include:
- Reducing absolute Scope 1 and 2 GHG emissions by 50% by 2030, using 2021 as the base year.
- Increasing active annual sourcing of renewable electricity from 23% in 2021 to 100% by the end of 2024 and maintaining 100% renewable electricity sourcing through 2030.
- Reducing absolute Scope 3 GHG emissions from purchased goods and services, fuel and energy-related activities, upstream transportation and distribution, and waste generated in operations by 20% by 2028, also from a 2021 base year.
- Ensuring that 63% of its suppliers, by emissions covering purchased goods and services, capital goods, and upstream transportation and distribution, have science-based targets by 2028.
For long-term targets, Mölnlycke aims to reduce absolute Scope 1 and 2 GHG emissions by 90% by 2050 from a 2021 base year. Additionally, they commit to reducing Scope 3 GHG emissions by 97% per tonne of sold product within the same timeframe.
Assessing Molnlycke as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Molnlycke and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Molnlycke’s Climate Goals (2030 & 2050)
7 goals2050
90% reduction in Scope 2
Mölnlycke Health Care commits to reduce absolute scope 2 GHG emissions 90% by 2050 from a 2021 base year.
At risk90%
2030
50% reduction in Scope 2
Mölnlycke Health Care commits to reduce absolute scope 2 GHG emissions 50% by 2030 from a 2021 base year.
At risk50%
2050
90% reduction in Scope 1
Mölnlycke Health Care commits to reduce absolute scope 1 GHG emissions 90% by 2050 from a 2021 base year.
Behind target90%
See all 7 climate goals
Sign up to see all goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
10 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
2030 targetSee details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Molnlycke7 months ago
100
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Molnlycke’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more